Affinity Asset Advisors LLC 13D and 13G filings for Forte Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-01-29 7:57 pm Sale | 2026-01-22 | 13G | FORTE BIOSCIENCES INC FBRX | Affinity Asset Advisors LLC | 834,964 6.700% | -27,436 (-3.18%) | Filing |
| 2025-12-23 5:15 pm Purchase | 2025-12-17 | 13G | FORTE BIOSCIENCES INC FBRX | Affinity Asset Advisors LLC | 862,400 6.900% | 862,400 (New Position) | Filing |